Michele Orditura

Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) is an Independent Prognostic Indicator of Worse Outcome in Gastric Cancer Patients

Eva Lieto, Francesca Ferraraccio, Michele Orditura et al. · Annals of Surgical Oncology · 2007 · 238 citations

Independent Prognostic Indicator, Worse Outcome, Angiogenesis +9

Prognostic Significance of Circulating IL-10 and IL-6 Serum Levels in Colon Cancer Patients Undergoing Surgery

Gennaro Galizia, Michele Orditura, Ciro Romano et al. · Clinical Immunology · 2002 · 230 citations

Prognostic Biomarkers, Surgical Oncology, Colon Cancer Patients +13

Naples Prognostic Score, Based on Nutritional and Inflammatory Status, is an Independent Predictor of Long-term Outcome in Patients Undergoing Surgery for Colorectal Cancer

Gennaro Galizia, Eva Lieto, A Auricchio et al. · Diseases of the Colon & Rectum · 2017 · 230 citations

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients

Ferdinando De Vita, Michele Orditura, Elide Matano et al. · British Journal of Cancer · 2005 · 180 citations · Full text

Gastrointestinal Oncology, Advanced Gastric Cancer, Medicine +12

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial

Sandro Pignata, Domenica Lorusso, Giovanni Scambia et al. · The Lancet Oncology · 2015 · 170 citations · Full text

Mito 11, Medicine, Metronomic Therapy +8